Nevro Corp (NYSE:NVRO)
$ 5.85 0 (0%) Market Cap: 218.11 Mil Enterprise Value: 186.70 Mil PE Ratio: 0 PB Ratio: 0.79 GF Score: 44/100

Nevro Corp at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 07:50PM GMT
Release Date Price: $121.94 (+3.64%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Great. Good afternoon. Thanks, everybody, for joining us for our next session in the med tech track. I'm Matt Taylor, the UBS U.S. medical supplies and devices analyst. And I'm really pleased to be joined by management from Nevro. So we have a few members of the management team on the line, including Keith Grossman, the Chairman, CEO and President; Andrew Galligan, the CFO; and also Juliet Cunningham, the Vice President of Investor Relations. So the format for today's call is that we're going to have a 40-minute fireside chat session, where I'll be moderating Q&A. If anybody has questions they'd like to ask, you can just e-mail me directly to get your questions in or through the webcast app. So with that, I just want to thank everybody from the team for joining, and welcome to the call.

D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President

Thanks, Matt. Thanks for having us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot